|
KMID : 1094720100150010066
|
|
Biotechnology and Bioprocess Engineering
2010 Volume.15 No. 1 p.66 ~ p.75
|
|
|
Strategies for Oral Delivery of Macromolecule Drugs
|
|
Park Jin-Woo
Kim Sang-Kyoon
Taslim Ahmed Al-Hilal
Byun Young-Ro
Jeon Ok-Cheol
Moon Hyun-Tae
|
|
|
Abstract
|
|
|
|
Advances in biotechnology, gene manipulation, and protein engineering for macromolecule drugs, such as insulin, parathyroid hormone (PTH), calcitonin, human growth hormone, erythropoietin (EPO), and peptide YY (PYY) allow commercial production in large scale for diverse therapeutic uses. Other macromolecules, such as mucopolysaccharide heparin, have expanded markets through improvements in their pharmacokinetic and pharmacological effects. However, most products are available only as injectable forms and are limited to patients with no alternative therapeutic choices. Orally available macromolecule formulations are still unmet needs for improving patient compliance and expanding administration paradigms and indications. Oral delivery technologies including carrier systems, absorption enhancers, protease inhibitors, and modification by conjugating transporter or receptor recognition molecules have been developed and some are undergoing clinical studies. In this review, we discuss major obstacles for oral absorption of macromolecule drugs and summarize recent strategies to overcome the huddles related to enhancing intestinal permeation.
|
|
|
KEYWORD
|
|
|
oral delivery, macromolecule drugs, oral absorption, permeability, enhancer
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|